论文部分内容阅读
近年来,我们通过使用国产尿激酶(UK,丹东鸭绿江制药厂)快速大剂量静脉给药治疗急性心肌梗塞(AMI),探讨UK治疗AMI提高冠脉再通的临床研究,现报告如下。资料与方法 1.病例选择本文15例病人(1989年1月～1991年12月入院)均符合WHO关于AMI诊断标准,并具下列条件:(1)胸痛发作至入院时间≤6小时;(2)舌下含硝酸甘油后胸痛及ST段抬高仍持续存在;(3)坏死性Q波无严重过深者;(4)年龄≤70岁;(5)无严重高血压等溶栓治疗禁忌症。其中男性9例,女性6例,平均年龄58.5岁。广泛前壁4例、
In recent years, we through the use of domestic urokinase (UK, Dandong Yalu River Pharmaceutical Factory) rapid high-dose intravenous administration of acute myocardial infarction (AMI) to explore UK treatment of AMI improve coronary recanalization clinical reports are as follows. Materials and Methods 1. Case Selection 15 cases of patients (January 1989 ~ December 1991 admission) are in line with WHO diagnostic criteria for AMI, and with the following conditions: (1) onset of chest pain to admission time ≤ 6 hours; (2 ) Sublingual nitroglycerin after chest pain and ST segment elevation persists; (3) no serious necrosis of the Q wave was too deep; (4) age ≤ 70 years; (5) no serious hypertension and other thrombolytic treatment taboo disease. There were 9 males and 6 females, with an average age of 58.5 years. 4 cases of extensive anterior wall,